Indian J Pharm Close
 

Figure 2: Immobility test, effect of granulocyte-colony stimulating factor on FST test in 6-hydroxydopamine (6-OHDA) induced Parkinson's disease model of rats, *P < 0.05, as compared to control; $P < 0.05, as compared to sham; #P < 0.05, as compared to 6-OHDA + vehicle group, a P < 0.05, as compared to L-DOPA/carbidopa

Figure 2: Immobility test, effect of granulocyte-colony stimulating factor on FST test in 6-hydroxydopamine (6-OHDA) induced Parkinson's disease model of rats, *<i>P</i> < 0.05, as compared to control; $<i>P</i> < 0.05, as compared to sham; #<i>P</i> < 0.05, as compared to 6-OHDA + vehicle group, a <i>P</i> < 0.05, as compared to L-DOPA/carbidopa